Keywords: drugmakers, hit, japan, tax, hikes, japanese, subsidiaries
DRUGMAKERS HIT BY JAPAN TAX HIKES
Article | 23 May 1994
Japanese subsidiaries of European and US pharmaceutical companies, already hit by government-mandated price cuts effective April 1 have, along with many ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
